These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27144431)

  • 1. Identification of miR-34a-target interactions by a combined network based and experimental approach.
    Hart M; Rheinheimer S; Leidinger P; Backes C; Menegatti J; Fehlmann T; Grässer F; Keller A; Meese E
    Oncotarget; 2016 Jun; 7(23):34288-99. PubMed ID: 27144431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics Study and Experimental Evaluation of miR-182, and miR-34 Expression Profiles in Tuberculosis and Lung Cancer.
    Alimardanian L; Soltani BM; Irani S; Sheikhpour M
    Tuberc Respir Dis (Seoul); 2024 Jul; 87(3):398-408. PubMed ID: 38616694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental capture of miRNA targetomes: disease-specific 3'UTR library-based miRNA targetomics for Parkinson's disease.
    Hart M; Kern F; Fecher-Trost C; Krammes L; Aparicio E; Engel A; Hirsch P; Wagner V; Keller V; Schmartz GP; Rheinheimer S; Diener C; Fischer U; Mayer J; Meyer MR; Flockerzi V; Keller A; Meese E
    Exp Mol Med; 2024 Apr; 56(4):935-945. PubMed ID: 38556547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease.
    Hart M; Diener C; Lunkes L; Rheinheimer S; Krammes L; Keller A; Meese E
    Mol Med; 2023 Apr; 29(1):43. PubMed ID: 37013480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mulberry Leaf (
    Yang TY; Yu MH; Wu YL; Hong CC; Chen CS; Chan KC; Wang CJ
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of Protein Expression after CRISPR/Cas9 Knockout of miRNA-142 in Cell Lines Derived from Diffuse Large B-Cell Lymphoma.
    Menegatti J; Nakel J; Stepanov YK; Caban KM; Ludwig N; Nord R; Pfitzner T; Yazdani M; Vilimova M; Kehl T; Lenhof HP; Philipp SE; Meese E; Fröhlich T; Grässer FA; Hart M
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia.
    Del Gaizo M; Sergio I; Lazzari S; Cialfi S; Pelullo M; Screpanti I; Felli MP
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro.
    Yu MH; Hung TW; Wang CC; Wu SW; Yang TW; Yang CY; Tseng TH; Wang CJ
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of microRNA-34a rs2666433 (A/G) Variant with Systemic Lupus Erythematosus in Female Patients: A Case-Control Study.
    Ismail NM; Toraih EA; Mohammad MHS; Alshammari EM; Fawzy MS
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.
    MotieGhader H; Safavi E; Rezapour A; Amoodizaj FF; Iranifam RA
    Sci Rep; 2021 Nov; 11(1):21872. PubMed ID: 34750486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of atherosclerosis in HIV positive persons.
    Cornwell A; Palli R; Singh MV; Benoodt L; Tyrell A; Abe JI; Schifitto G; Maggirwar SB; Thakar J
    Sci Rep; 2021 Feb; 11(1):3232. PubMed ID: 33547350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of human microRNA target pathways enables evaluation of target prediction tools.
    Kern F; Krammes L; Danz K; Diener C; Kehl T; Küchler O; Fehlmann T; Kahraman M; Rheinheimer S; Aparicio-Puerta E; Wagner S; Ludwig N; Backes C; Lenhof HP; von Briesen H; Hart M; Keller A; Meese E
    Nucleic Acids Res; 2021 Jan; 49(1):127-144. PubMed ID: 33305319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
    Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-Branch.
    Krammes L; Hart M; Rheinheimer S; Diener C; Menegatti J; Grässer F; Keller A; Meese E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32531952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A network view of microRNA and gene interactions in different pathological stages of colon cancer.
    Wen J; Hall B; Shi X
    BMC Med Genomics; 2019 Dec; 12(Suppl 7):158. PubMed ID: 31888617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TNRC6 (GW182) Proteins Is Not Necessary for Gene Silencing by Fully Complementary RNA Duplexes.
    Liu Z; Johnson ST; Zhang Z; Corey DR
    Nucleic Acid Ther; 2019 Dec; 29(6):323-334. PubMed ID: 31670606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34a as hub of T cell regulation networks.
    Hart M; Walch-Rückheim B; Krammes L; Kehl T; Rheinheimer S; Tänzer T; Glombitza B; Sester M; Lenhof HP; Keller A; Meese E
    J Immunother Cancer; 2019 Jul; 7(1):187. PubMed ID: 31311583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling.
    Hart M; Walch-Rückheim B; Friedmann KS; Rheinheimer S; Tänzer T; Glombitza B; Sester M; Lenhof HP; Hoth M; Schwarz EC; Keller A; Meese E
    Cell Death Dis; 2019 Jan; 10(2):46. PubMed ID: 30718475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of intracellular calcium signaling by microRNA-34a-5p.
    Diener C; Hart M; Alansary D; Poth V; Walch-Rückheim B; Menegatti J; Grässer F; Fehlmann T; Rheinheimer S; Niemeyer BA; Lenhof HP; Keller A; Meese E
    Cell Death Dis; 2018 Sep; 9(10):1008. PubMed ID: 30262862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer.
    Kahraman M; Röske A; Laufer T; Fehlmann T; Backes C; Kern F; Kohlhaas J; Schrörs H; Saiz A; Zabler C; Ludwig N; Fasching PA; Strick R; Rübner M; Beckmann MW; Meese E; Keller A; Schrauder MG
    Sci Rep; 2018 Aug; 8(1):11584. PubMed ID: 30072748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.